130 related articles for article (PubMed ID: 15483265)
21. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
22. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.
Féraudet C; Morel N; Simon S; Volland H; Frobert Y; Créminon C; Vilette D; Lehmann S; Grassi J
J Biol Chem; 2005 Mar; 280(12):11247-58. PubMed ID: 15618225
[TBL] [Abstract][Full Text] [Related]
23. Conformational variation between allelic variants of cell-surface ovine prion protein.
Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of a panel of monoclonal antibodies against native human cellular prion protein.
Jones M; McLoughlin V; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Hybridoma (Larchmt); 2009 Feb; 28(1):13-20. PubMed ID: 19132894
[TBL] [Abstract][Full Text] [Related]
25. Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.
Khalili-Shirazi A; Kaisar M; Mallinson G; Jones S; Bhelt D; Fraser C; Clarke AR; Hawke SH; Jackson GS; Collinge J
Biochim Biophys Acta; 2007 Nov; 1774(11):1438-50. PubMed ID: 17936697
[TBL] [Abstract][Full Text] [Related]
26. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants.
Harmeyer S; Pfaff E; Groschup MH
J Gen Virol; 1998 Apr; 79 ( Pt 4)():937-45. PubMed ID: 9568991
[TBL] [Abstract][Full Text] [Related]
27. Packaging of prions into exosomes is associated with a novel pathway of PrP processing.
Vella LJ; Sharples RA; Lawson VA; Masters CL; Cappai R; Hill AF
J Pathol; 2007 Apr; 211(5):582-590. PubMed ID: 17334982
[TBL] [Abstract][Full Text] [Related]
28. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines.
Beringue V; Vilette D; Mallinson G; Archer F; Kaisar M; Tayebi M; Jackson GS; Clarke AR; Laude H; Collinge J; Hawke S
J Biol Chem; 2004 Sep; 279(38):39671-6. PubMed ID: 15133046
[TBL] [Abstract][Full Text] [Related]
29. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
30. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
Filesi I; Cardinale A; Mattei S; Biocca S
J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
[TBL] [Abstract][Full Text] [Related]
31. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
32. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.
Polymenidou M; Heppner FL; Pellicioli EC; Urich E; Miele G; Braun N; Wopfner F; Schätzl HM; Becher B; Aguzzi A
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14670-6. PubMed ID: 15292505
[TBL] [Abstract][Full Text] [Related]
33. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
[TBL] [Abstract][Full Text] [Related]
34. Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains.
Korth C; Kaneko K; Prusiner SB
J Gen Virol; 2000 Oct; 81(Pt 10):2555-2563. PubMed ID: 10993946
[TBL] [Abstract][Full Text] [Related]
35. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
[TBL] [Abstract][Full Text] [Related]
36. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.
Zulianello L; Kaneko K; Scott M; Erpel S; Han D; Cohen FE; Prusiner SB
J Virol; 2000 May; 74(9):4351-60. PubMed ID: 10756050
[TBL] [Abstract][Full Text] [Related]
37. Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo.
Sadowski MJ; Pankiewicz J; Prelli F; Scholtzova H; Spinner DS; Kascsak RB; Kascsak RJ; Wisniewski T
Neurobiol Dis; 2009 May; 34(2):267-78. PubMed ID: 19385058
[TBL] [Abstract][Full Text] [Related]
38. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
39. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
40. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
